Global Oncolytic Virus Market Research Report 2022(Status and Outlook)
Global Oncolytic Virus Market Research Report 2022(Status and Outlook)
Abstract
Report Overview
An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 2th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
To date, two genetically engineered oncolytic viruses have been approved for marketing as drugs. One is Oncorine (H11, the same construct as ONYX‐15),9 an E1B‐deleted adenovirus, which was approved in China for head and neck cancer and esophagus cancer in 25. The use and clinical data of Oncorine is so far limited to China. The other is T‐Vec (talimogene laherparepvec, IMLYGIC, formerly OncoVEXGM‐CSF), which was approved for melanoma by the FDA in the USA in October 215 and was subsequently approved in Europe in January 216 and in Australia in May 216. For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. Market competition is intense. Amgen, Shanghai Sunway Biotech, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry. Other players include Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics and Cold Genesys, etc.
The Global Oncolytic Virus Market Size was estimated at USD 16.02 million in 2021 and is projected to reach USD 25.50 million by 2028, exhibiting a CAGR of 6.87% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Oncolytic Virus market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oncolytic Virus Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oncolytic Virus market in any manner.
Global Oncolytic Virus Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
•Amgen
•Shanghai Sunway Biotech
Market Segmentation (by Type)
•Imlygic
•Oncorine
•Others
Market Segmentation (by Application)
•Melanoma
•Other Cancers
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Oncolytic Virus Market
• Overview of the regional outlook of the Oncolytic Virus Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncolytic Virus Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Content
TABLE OF CONTENTS
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Oncolytic Virus
1.2 Key Market Segments
1.2.1 Oncolytic Virus Segment by Type
1.2.2 Oncolytic Virus Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Oncolytic Virus Market Overview
2.1 Global Market Overview
2.1.1 Global Oncolytic Virus Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Oncolytic Virus Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oncolytic Virus Market Competitive Landscape
3.1 Global Oncolytic Virus Sales by Manufacturers (2017-2022)
3.2 Global Oncolytic Virus Revenue Market Share by Manufacturers (2017-2022)
3.3 Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oncolytic Virus Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Oncolytic Virus Sales Sites, Area Served, Product Type
3.6 Oncolytic Virus Market Competitive Situation and Trends
3.6.1 Oncolytic Virus Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oncolytic Virus Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Oncolytic Virus Industry Chain Analysis
4.1 Oncolytic Virus Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Oncolytic Virus Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Oncolytic Virus Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncolytic Virus Sales Market Share by Type (2017-2022)
6.3 Global Oncolytic Virus Market Size Market Share by Type (2017-2022)
6.4 Global Oncolytic Virus Price by Type (2017-2022)
7 Oncolytic Virus Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncolytic Virus Market Sales by Application (2017-2022)
7.3 Global Oncolytic Virus Market Size (M USD) by Application (2017-2022)
7.4 Global Oncolytic Virus Sales Growth Rate by Application (2017-2022)
8 Oncolytic Virus Market Segmentation by Region
8.1 Global Oncolytic Virus Sales by Region
8.1.1 Global Oncolytic Virus Sales by Region
8.1.2 Global Oncolytic Virus Sales Market Share by Region
8.2 North America
8.2.1 North America Oncolytic Virus Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncolytic Virus Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncolytic Virus Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncolytic Virus Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncolytic Virus Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profiled
9.1 Amgen
9.1.1 Amgen Oncolytic Virus Basic Information
9.1.2 Amgen Oncolytic Virus Product Overview
9.1.3 Amgen Oncolytic Virus Product Market Performance
9.1.4 Amgen Business Overview
9.1.5 Amgen Oncolytic Virus SWOT Analysis
9.1.6 Amgen Recent Developments
9.2 Shanghai Sunway Biotech
9.2.1 Shanghai Sunway Biotech Oncolytic Virus Basic Information
9.2.2 Shanghai Sunway Biotech Oncolytic Virus Product Overview
9.2.3 Shanghai Sunway Biotech Oncolytic Virus Product Market Performance
9.2.4 Shanghai Sunway Biotech Business Overview
9.2.5 Shanghai Sunway Biotech Oncolytic Virus SWOT Analysis
9.2.6 Shanghai Sunway Biotech Recent Developments
10 Oncolytic Virus Market Forecast by Region
10.1 Global Oncolytic Virus Market Size Forecast
10.2 Global Oncolytic Virus Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oncolytic Virus Market Size Forecast by Country
10.2.3 Asia Pacific Oncolytic Virus Market Size Forecast by Region
10.2.4 South America Oncolytic Virus Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oncolytic Virus by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Oncolytic Virus Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Oncolytic Virus by Type (2022-2028)
11.1.2 Global Oncolytic Virus Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Oncolytic Virus by Type (2022-2028)
11.2 Global Oncolytic Virus Market Forecast by Application (2022-2028)
11.2.1 Global Oncolytic Virus Sales (K Units) Forecast by Application
11.2.2 Global Oncolytic Virus Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oncolytic Virus Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Oncolytic Virus Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Oncolytic Virus Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Oncolytic Virus Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Oncolytic Virus Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus as of 2021)
Table 10. Global Market Oncolytic Virus Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Oncolytic Virus Sales Sites and Area Served
Table 12. Manufacturers Oncolytic Virus Product Type
Table 13. Global Oncolytic Virus Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Oncolytic Virus
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oncolytic Virus Market Challenges
Table 22. Market Restraints
Table 23. Global Oncolytic Virus Sales by Type (K Units)
Table 24. Global Oncolytic Virus Market Size by Type (M USD)
Table 25. Global Oncolytic Virus Sales (K Units) by Type (2017-2022)
Table 26. Global Oncolytic Virus Sales Market Share by Type (2017-2022)
Table 27. Global Oncolytic Virus Market Size (M USD) by Type (2017-2022)
Table 28. Global Oncolytic Virus Market Size Share by Type (2017-2022)
Table 29. Global Oncolytic Virus Price (USD/Unit) by Type (2017-2022)
Table 30. Global Oncolytic Virus Sales (K Units) by Application
Table 31. Global Oncolytic Virus Market Size by Application
Table 32. Global Oncolytic Virus Sales by Application (2017-2022) & (K Units)
Table 33. Global Oncolytic Virus Sales Market Share by Application (2017-2022)
Table 34. Global Oncolytic Virus Sales by Application (2017-2022) & (M USD)
Table 35. Global Oncolytic Virus Market Share by Application (2017-2022)
Table 36. Global Oncolytic Virus Sales Growth Rate by Application (2017-2022)
Table 37. Global Oncolytic Virus Sales by Region (2017-2022) & (K Units)
Table 38. Global Oncolytic Virus Sales Market Share by Region (2017-2022)
Table 39. North America Oncolytic Virus Sales by Country (2017-2022) & (K Units)
Table 40. Europe Oncolytic Virus Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Oncolytic Virus Sales by Region (2017-2022) & (K Units)
Table 42. South America Oncolytic Virus Sales by Country (2017-2022) & (K Units)
An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 2th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
To date, two genetically engineered oncolytic viruses have been approved for marketing as drugs. One is Oncorine (H11, the same construct as ONYX‐15),9 an E1B‐deleted adenovirus, which was approved in China for head and neck cancer and esophagus cancer in 25. The use and clinical data of Oncorine is so far limited to China. The other is T‐Vec (talimogene laherparepvec, IMLYGIC, formerly OncoVEXGM‐CSF), which was approved for melanoma by the FDA in the USA in October 215 and was subsequently approved in Europe in January 216 and in Australia in May 216. For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. Market competition is intense. Amgen, Shanghai Sunway Biotech, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry. Other players include Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics and Cold Genesys, etc.
The Global Oncolytic Virus Market Size was estimated at USD 16.02 million in 2021 and is projected to reach USD 25.50 million by 2028, exhibiting a CAGR of 6.87% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Oncolytic Virus market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oncolytic Virus Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oncolytic Virus market in any manner.
Global Oncolytic Virus Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
•Amgen
•Shanghai Sunway Biotech
Market Segmentation (by Type)
•Imlygic
•Oncorine
•Others
Market Segmentation (by Application)
•Melanoma
•Other Cancers
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Oncolytic Virus Market
• Overview of the regional outlook of the Oncolytic Virus Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncolytic Virus Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Oncolytic Virus
1.2 Key Market Segments
1.2.1 Oncolytic Virus Segment by Type
1.2.2 Oncolytic Virus Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Oncolytic Virus Market Overview
2.1 Global Market Overview
2.1.1 Global Oncolytic Virus Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Oncolytic Virus Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oncolytic Virus Market Competitive Landscape
3.1 Global Oncolytic Virus Sales by Manufacturers (2017-2022)
3.2 Global Oncolytic Virus Revenue Market Share by Manufacturers (2017-2022)
3.3 Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oncolytic Virus Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Oncolytic Virus Sales Sites, Area Served, Product Type
3.6 Oncolytic Virus Market Competitive Situation and Trends
3.6.1 Oncolytic Virus Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oncolytic Virus Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Oncolytic Virus Industry Chain Analysis
4.1 Oncolytic Virus Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Oncolytic Virus Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Oncolytic Virus Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncolytic Virus Sales Market Share by Type (2017-2022)
6.3 Global Oncolytic Virus Market Size Market Share by Type (2017-2022)
6.4 Global Oncolytic Virus Price by Type (2017-2022)
7 Oncolytic Virus Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncolytic Virus Market Sales by Application (2017-2022)
7.3 Global Oncolytic Virus Market Size (M USD) by Application (2017-2022)
7.4 Global Oncolytic Virus Sales Growth Rate by Application (2017-2022)
8 Oncolytic Virus Market Segmentation by Region
8.1 Global Oncolytic Virus Sales by Region
8.1.1 Global Oncolytic Virus Sales by Region
8.1.2 Global Oncolytic Virus Sales Market Share by Region
8.2 North America
8.2.1 North America Oncolytic Virus Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncolytic Virus Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncolytic Virus Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncolytic Virus Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncolytic Virus Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profiled
9.1 Amgen
9.1.1 Amgen Oncolytic Virus Basic Information
9.1.2 Amgen Oncolytic Virus Product Overview
9.1.3 Amgen Oncolytic Virus Product Market Performance
9.1.4 Amgen Business Overview
9.1.5 Amgen Oncolytic Virus SWOT Analysis
9.1.6 Amgen Recent Developments
9.2 Shanghai Sunway Biotech
9.2.1 Shanghai Sunway Biotech Oncolytic Virus Basic Information
9.2.2 Shanghai Sunway Biotech Oncolytic Virus Product Overview
9.2.3 Shanghai Sunway Biotech Oncolytic Virus Product Market Performance
9.2.4 Shanghai Sunway Biotech Business Overview
9.2.5 Shanghai Sunway Biotech Oncolytic Virus SWOT Analysis
9.2.6 Shanghai Sunway Biotech Recent Developments
10 Oncolytic Virus Market Forecast by Region
10.1 Global Oncolytic Virus Market Size Forecast
10.2 Global Oncolytic Virus Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oncolytic Virus Market Size Forecast by Country
10.2.3 Asia Pacific Oncolytic Virus Market Size Forecast by Region
10.2.4 South America Oncolytic Virus Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oncolytic Virus by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Oncolytic Virus Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Oncolytic Virus by Type (2022-2028)
11.1.2 Global Oncolytic Virus Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Oncolytic Virus by Type (2022-2028)
11.2 Global Oncolytic Virus Market Forecast by Application (2022-2028)
11.2.1 Global Oncolytic Virus Sales (K Units) Forecast by Application
11.2.2 Global Oncolytic Virus Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oncolytic Virus Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Oncolytic Virus Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Oncolytic Virus Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Oncolytic Virus Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Oncolytic Virus Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus as of 2021)
Table 10. Global Market Oncolytic Virus Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Oncolytic Virus Sales Sites and Area Served
Table 12. Manufacturers Oncolytic Virus Product Type
Table 13. Global Oncolytic Virus Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Oncolytic Virus
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oncolytic Virus Market Challenges
Table 22. Market Restraints
Table 23. Global Oncolytic Virus Sales by Type (K Units)
Table 24. Global Oncolytic Virus Market Size by Type (M USD)
Table 25. Global Oncolytic Virus Sales (K Units) by Type (2017-2022)
Table 26. Global Oncolytic Virus Sales Market Share by Type (2017-2022)
Table 27. Global Oncolytic Virus Market Size (M USD) by Type (2017-2022)
Table 28. Global Oncolytic Virus Market Size Share by Type (2017-2022)
Table 29. Global Oncolytic Virus Price (USD/Unit) by Type (2017-2022)
Table 30. Global Oncolytic Virus Sales (K Units) by Application
Table 31. Global Oncolytic Virus Market Size by Application
Table 32. Global Oncolytic Virus Sales by Application (2017-2022) & (K Units)
Table 33. Global Oncolytic Virus Sales Market Share by Application (2017-2022)
Table 34. Global Oncolytic Virus Sales by Application (2017-2022) & (M USD)
Table 35. Global Oncolytic Virus Market Share by Application (2017-2022)
Table 36. Global Oncolytic Virus Sales Growth Rate by Application (2017-2022)
Table 37. Global Oncolytic Virus Sales by Region (2017-2022) & (K Units)
Table 38. Global Oncolytic Virus Sales Market Share by Region (2017-2022)
Table 39. North America Oncolytic Virus Sales by Country (2017-2022) & (K Units)
Table 40. Europe Oncolytic Virus Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Oncolytic Virus Sales by Region (2017-2022) & (K Units)
Table 42. South America Oncolytic Virus Sales by Country (2017-2022) & (K Units)
Related Report
